Study Group: Physicians Who Treat Patients with Pompe Disease (US)(?)
Council Members in this Study Group: 23
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Related Study Groups
| Study Group Name | Members |
|---|---|
| Physicians who Treat Gaucher's Disease (US) | 17 |
| Cerezyme Prescribers | 25 |
| Medical Geneticists (US) | 85 |
| Pediatricians (US) | 1667 |
| Physicians who Treat Fabry Disease (US) | 24 |
| Physicians Who Treat PKU (US) | 34 |
| Physicians Who Treat Hunter Syndrome (US) | 10 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Personal Medicine Not Ready for Prime Time! | 12-02-2008
Analysis of:
Personal medicine is goal of Eli Lilly & Co. | www.azcentral.com
Author: GLG Expert Contributor
Success in personal medicine will depend on significant technologic advancements beyond simply knowing an individual's complete DNA sequence. These include a better understanding of the genetic components leading to common disease and those determining drug metabolism. While the latter appears...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
- Lab, Academic Medical Center
Most Common Job Types:
- Physician - Attending Physician
- Physician - Division Head
- Physician - Director
- Professor
- Director
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate